Literature DB >> 11096067

Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D.

T I Slepak1, K A Webster, J Zang, H Prentice, A O'Dowd, M N Hicks, N H Bishopric.   

Abstract

The transcriptional integrator p300 regulates gene expression by interaction with sequence-specific DNA-binding proteins and local remodeling of chromatin. p300 is required for cardiac-specific gene transcription, but the molecular basis of this requirement is unknown. Here we report that the MADS (MCM-1, agamous, deficiens, serum response factor) box transcription factor myocyte enhancer factor-2D (MEF-2D) acts as the principal conduit for cardiac transcriptional activation by p300. p300 activation of the native 2130-base pair human skeletal alpha-actin promoter required a single hybrid MEF-2/GATA-4 DNA motif centered at -1256 base pairs. Maximal expression of the promoter in cultured myocytes and in vivo correlated with binding of both MEF-2 and p300, but not GATA-4, to this AT-rich motif. p300 and MEF-2 were coprecipitated from cardiac nuclear extracts by an oligomer containing this element. p300 was found exclusively in a complex with MEF-2D at this and related sites in other cardiac-restricted promoters. MEF-2D, but not other MEFs, significantly potentiated cardiac-specific transcription by p300. No physical or functional interaction was observed between p300 and other factors implicated in skeletal actin transcription, including GATA-4, TEF-1, or SRF. These results show that, in the intact cell, p300 interactions with its protein targets are highly selective and that MEF-2D is the preferred channel for p300-mediated transcriptional control in the heart.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11096067     DOI: 10.1074/jbc.M004625200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300.

Authors:  Andreas Müller; Andreas Ritzkowsky; Gertrud Steger
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Direct interaction between nucleosome assembly protein 1 and the papillomavirus E2 proteins involved in activation of transcription.

Authors:  Manuela Rehtanz; Hanns-Martin Schmidt; Ursula Warthorst; Gertrud Steger
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

Review 3.  Epigenetics of the failing heart.

Authors:  José Marín-García; Alexander T Akhmedov
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

4.  Reversal of pathological cardiac hypertrophy via the MEF2-coregulator interface.

Authors:  Jianqin Wei; Shaurya Joshi; Svetlana Speransky; Christopher Crowley; Nimanthi Jayathilaka; Xiao Lei; Yongqing Wu; David Gai; Sumit Jain; Michael Hoosien; Yan Gao; Lin Chen; Nanette H Bishopric
Journal:  JCI Insight       Date:  2017-09-07

5.  The control operated by the cell cycle machinery on MEF2 stability contributes to the downregulation of CDKN1A and entry into S phase.

Authors:  Eros Di Giorgio; Enrico Gagliostro; Andrea Clocchiatti; Claudio Brancolini
Journal:  Mol Cell Biol       Date:  2015-03-02       Impact factor: 4.272

6.  Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development.

Authors:  Lawryn H Kasper; Tomofusa Fukuyama; Michelle A Biesen; Fayçal Boussouar; Caili Tong; Antoine de Pauw; Peter J Murray; Jan M A van Deursen; Paul K Brindle
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

7.  The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.

Authors:  Michael D Kritzer; Jinliang Li; Catherine L Passariello; Marjorie Gayanilo; Hrishikesh Thakur; Joseph Dayan; Kimberly Dodge-Kafka; Michael S Kapiloff
Journal:  Circ Heart Fail       Date:  2014-05-08       Impact factor: 8.790

Review 8.  Signaling and transcriptional networks in heart development and regeneration.

Authors:  Benoit G Bruneau
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

9.  Cardiac p300 is involved in myocyte growth with decompensated heart failure.

Authors:  Tetsuhiko Yanazume; Koji Hasegawa; Tatsuya Morimoto; Teruhisa Kawamura; Hiromichi Wada; Akira Matsumori; Yosuke Kawase; Maretoshi Hirai; Toru Kita
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

10.  Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300.

Authors:  Jian Qin Wei; Lina A Shehadeh; James M Mitrani; Monica Pessanha; Tatiana I Slepak; Keith A Webster; Nanette H Bishopric
Journal:  Circulation       Date:  2008-08-12       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.